Moderna's latest flu vaccine trial results are in, and they're looking good. The company's experimental mRNA-based flu shot showed a stronger immune response than the standard flu vaccine currently in use. This is big news, especially since Moderna is also working on a combo shot that targets both flu and COVID-19. Earlier this year, Moderna pulled its application f...

The U. S. government has taken a surprising step back in its fight against potential health threats. The Department of Health and Human Services (HHS) recently canceled a significant contract with Moderna, a biotech company known for its COVID-19 vaccine. This contract, worth $766 million, was aimed at developing a new vaccine for bird flu, specifically the H5N1 stra...